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CONNECTIVE TISSUE ACTIVATION 
XX. Stimulation of Prostaglandin Secretion by Mediators from 
Lymphocytes (CTAP-I) and Platelets (CTAP-111) 
C. WILLIAM CASTOR and SUMER PEK 
Connective tissue activating peptides from lym- 
phocytes (CTAP-I) and platelets (CTAP-111) are known 
to stimulate glycosaminoglycan synthesis, glycolysis, 
and mitogenesis in connective tissue cell cultures. Di- 
rect evidence suggested that increased accumulation of 
cyclic AMP was involved in the action of these peptide 
agonists, and increased prostaglandin E synthesis was 
postulated on the basis of indirect evidence. In the pres- 
ent experiments, CTAP-I and -111 were incubated with 
human and murine cells in culture, and prostaglandin E 
was measured by radioimmunoassay using antibody di- 
rected primarily to prostaglandin E2. Both CTAP-I and 
-111 markedly stimulated the elaboration of prostaglan- 
din E into culture medium, the earliest evidence of in- 
creased synthesis occurring at 4 hours with maximal 
concentrations found at 24 hours. Substantial residual 
stimulation persisted at least through 48 hours. Indo- 
methacin (13.0 pg/ml) obliterated basal and incremental 
synthesis of prostaglandin in the presence of mediators. 
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Cycloheximide (8.7 pg/ml) did not affect the stimulation 
of prostaglandin synthesis by CTAP-I and -111. Three 
nonrheumatoid and 3 rheumatoid synovial cell strains 
showed similar basal levels of prostaglandin E and simi- 
lar responses to CTAP-I. A murine fibroblast cell strain 
(3T3) showed increased prostaglandin E synthesis on 
exposure to CTAP-I, and the KB tumor cell strain was 
markedly stimulated by CTAP-111. These studies con- 
firm the increased synthesis of E series prostaglandins 
postulated to occur in human connective tissue cells on 
exposure to CTAP-I and -111, and clarify the mechanism 
of action of these agonists on “activated” target cells. 
The importance of elevated extracellular concentrations 
of prostaglandins is uncertain, although they may act di- 
rectly on sensitive cell types as well as potentiate the 
actions of CTAP-I and -111 on neighboring cells. 
Recent data suggest that substances released 
from leukocytes and platelets during the acute phase of 
the inflammatory response may be instrumental in acti- 
vating connective tissue and initiating repair activities 
in that cellular system (2-5). Products (connective tissue 
activating peptides [CTAP]) derived from platelets dur- 
ing the coagulation sequence (CTAP-111), from lym- 
phoid cells (CTAP-I), and from exudative leukocytes 
(CTAP-PMN) are all capable of stimulating connective 
tissue cells. CTAP-I (lymphocytes) stimulates energy 
metabolism and glycosaminoglycan synthesis, whereas 
CTAP-I11 (platelets) possesses the additional ability to 
stimulate DNA synthesis. The lymphocyte and platelet 
materials have been isolated and characterized, the 
amino acid composition of both is known, and the se- 
quence of the platelet factor has been reported (4,6). 
One of the major differences is the essential sulfkydryl 
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Table 1. Basal and CTAP stimulated PGE2 synthesis in normal and 
rheumatoid synovial cultures 
din E (PGE) upon exposure to either CTAP-I or CTAP- 
111. 
PGE pg/1.5 X lo5 cells/24 hrs* 
Control CTAP-I CTAP-111 MATERIALS AND METHODS 
Normal cell strains 
CF-C 76 f 36 236 f 97t 184 +- 47t 
CF-G 115 f 5 5490 f 853$ 240 f 985 
CB-E 5 0 f  18 703 f 537 552 f 238# 
WP-F 1 3 f 7  166 & 59** 762 f 1817 
Rheumatoid cell strains 
CS-F 477 f 101 4773 654* 1178 * i28n 
OD-H 1 3 f 3  372 f 129tt 1590 * 540ff 
HD-E 113 f 4 2  815 f 14+ 333 f 114# 
* Data are the mean f 1 SD of triplicate measurements in a single ex- 
periment. Similar data were obtained when cell strains CF, WP, and 
CS were studied in additional experiments. 
t P < 0.025. * P < 0.001. 
fj P < 0.20. 
1 P < 0.00s. 
tt P < 0.01. 
** P < 0.02. 
component of CTAP-I as opposed to two essential di- 
sulfide bridges in the CTAP-I11 platelet factor. 
An early proposal for the mechanism of action of 
the connective tissue activating peptides suggested that 
they interacted with the cell membrane at a complex re- 
ceptor site (7). Stimulation of glycolysis and hy- 
aluronate synthesis was shown to depend on both RNA 
and protein synthesis, and this process appeared to re- 
quire the participation of a coupled prostaglandin-cyclic 
AMP system (7,8). This latter component of the mecha- 
nism of activation was thought to be important in mak- 
ing energy and carbon available for the glycosaminogly- 
can synthetic processes. Indirect evidence suggested a 
role for the participation of prostaglandins in the mech- 
anism of synovial cell activation by CTAP. For in- 
stance, connective tissue activation was blocked by in- 
hibiting prostaglandin synthesis with indomethacin and 
acetylsalicylic acid, or by antagonizing the action of 
prostaglandins with agents such as polyphloretin phos- 
phate or 7-oxa-13-prostynoic acid (8). Further, we dem- 
onstrated earlier that the actions of connective tissue ac- 
tivating peptides were markedly potentiated by low 
concentrations of prostaglandins, which in and of them- 
selves had no measureable activity. Lastly, direct mea- 
surements of cellular cyclic AMP content showed this 
mediator to be substantially stimulated by the addition 
of prostaglandins of the E and F series to synovial cul- 
tures (8). 
In the present experiments, we provide direct 
evidence that synovial cell cultures release prostaglan- 
Cell culture methods. Human synovial membrane 
specimens were obtained at arthrotomy or amputation, and a 
portion of each was fixed for histology. The remainder of the 
samples was divided into 1 mm3 explants from which primary 
cell strains were developed, as previously reported (9). Human 
dermal cultures were established in a similar manner. Rheu- 
matoid synovial specimens were from patients fulfilling the 
American Rheumatism Association criteria (10). Guinea pig 
lung fibroblast cultures were established following enzymatic 
disaggregation of the tissue (1 1). Human and mammalian cell 
strains and lines were recovered from frozen storage for use in 
these studies as needed. Routine culture medium for human 
connective tissue cells consisted of 80% synthetic medium 
1066, 10% fetal calf serum, and 10% heat inactivated human 
serum supplemented with L-glutamine, penicillin, streptomy- 
cin, and 0.02M Hepes buffer. Human serum was inactivated at 
56°C for I hour. Cells were counted with an electronic cell 
counter (Model B, Coulter Electronics, Hialeah, FL). 
Sources of CTAP. CTAP-I was isolated from human 
spleen and from a continuous human lymphocyte line as re- 
ported earlier (2). CTAP-111 was isolated from outdated hu- 
man platelets by procedures published recently (4). 
Isotope incorporation studies. Incorporation of I4C- 
glucosamine into glycosaminoglycans (GAG) was carried out 
as described previously (12). In brief, fibroblasts were plated 
in well cultures at 20 X lo3 cells per well and nourished by 200 
p1 of medium containing 0.5 pCi/ml of D-[U-’4C]-glucosa- 
mine HCI. After 40 hours of incubation, the medium was re- 
moved, and the isotope content of macromolecular species in 
the medium was estimated by scintillation counting after sep- 
aration from unincorporated isotope as reported previously 
(12), or alternatively, by selectively precipitating the GAG on 
filter paper with cetylpyridinium chloride and washing away 
unincorporated isotope, a method to be reported in detail else- 
where. Characterization of glycosaminoglycan mixtures was 
accomplished by incubation of radiolabeled glycosaminogly- 
cans with specific carbohydrases before cetylpyridinium chlo- 
ride precipitation, washing, and measurement of radioactivity. 
Incubation conditions have been defined (13), and the speci- 
ficity of the fungal hyaluronidase (14) and chondroitinase (15) 
has been established. 
Radioimmunoassay (RIA) of PGE2 was carried out 
by standard methods with antisera from Miles-Yeda Ltd. (16). 
This antiserum showed less than 0.01% cross-reactivity with 
F-series prostaglandins, but showed 60% cross-reactivity with 
PGEI. Data were calculated in PGE2 equivalents from a 
PGE2 standard curve ranging from 7.8 to 500 pg/ml with a 
detection limit of approximately 900 fg/assay tube. Serum- 
free Eagle’s synthetic medium (ESM) was used for the cell 
culture experiments. This medium was shown not to contain 
any materials that interfere in the RIA for PGE2. One-half 
milliliter of medium was used to support 1.5 X lo5 cells in 
each culture well during these experiments. Cells were planted 
at zero time in serum containing medium and allowed to at- 
tach and spread; the following day the medium was changed 
to serum-free ESM and various additives as indicated, and in- 
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Table 2. Basal and CTAP stimulated PGE2 synthesis in nonsynovial 
cell cultures 
PGE pg/1.5 X lo5 cells/24 hrs 
Cell strain Control CTAP-I CTAP-I11 
CF-S-F human 
skin fibroblast 271 f 83 1162 f 64* - 
KB human 
epidermoid cancer 1165 f 122 1212 f 7 3 t  4487 f 1404$ 
Guinea pig lung 
fibroblast 743 + -4  1428+-527§ - 
3T3 murine 
fibroblast 757 f 120 1670 +- 352$ 236 f 231 
* P < 0.001. 
t Not significant. 
$ P < 0.02. 
8 CTAP-I-like material prepared from guinea pig spleen. P < 0.20. 
1 P < 0.005. 
cubation was carried out for 24 hours. Purified prostaglandins 
used in the culture experiments were made available through 
the courtesy of Dr. John E. Pike, the Upjohn Company, Kala- 
mazoo, Michigan. 
RESULTS 
Three normal synovial cell strains synthesized 
measureable amounts of prostaglandin E in the course 
of 24 hours (Table 1). These concentrations were sub- 
stantially increased by the addition of either CTAP-I or 
CTAP-111. Further, three rheumatoid synovial cell 
strains exhibited a similar increase in secretion of PGE 
on exposure to these mediators. The first rheumatoid 
cell culture that was studied had a very high basal rate 
of prostaglandin synthesis and proved to be very re- 
sponsive to both CTAP preparations. However, such 
high basal synthetic rates did not prove to be a consis- 
tent finding in all rheumatoid cultures (Table 1). 
Cell strains other than synovial cultures were 
also capable of releasing PGE in response to the CTAPs 
(Table 2). A human skin fibroblast strain synthesized 
four-fold more prostaglandin on exposure to CTAP-I, 
and a human epidermoid carcinoma cell strain proved 
to be quite sensitive to CTAP-I11 but failed to respond 
to the lymphocyte peptide. Both a primary lung fibro- 
blast strain and an established line of murine fibroblasts 
were responsive to CTAP-I. 
In two experiments, the increasing concentra- 
tions of prostaglandins induced by CTAP-I or CTAP- 
I11 were plotted against time (Figure 1). Both peptides 
stimulated increased PGE2 secretion detectable by 8 
hours; maximal values were observed by 24 hours 
(strain CB, Figure 1). An experiment with another pri- 
mary synovial cell strain suggested that the elevated 
concentrations of PGE in the media may decay rela- 
tively slowly (strain WP, Figure 1). A dose response 
curve for CTAP-I11 (Figure 2) indicated that the secre- 
tion of PGE into the culture medium is a function of 
CTAP-I11 concentration. Increases in CTAP-I concen- 
trations also lead to increased PGE secretion (data not 
shown). 
Comparative effects of prostaglandins on net I4C- 
GAG formation. Previous studies clearly showed that 
PGE1, PGE2, PGFla, and PGF2a stimulated GAG 
(hyaluronic acid) formation by human synovial cells in 
vitro (8). In the present study, we compared CTAP-I, 
CTAP-111, bovine insulin, and several prostaglandins 
for their capacity to stimulate ‘‘C-glucosamine incorpo- 
ration into hyaluronate secreted into the culture me- 
dium. In both experiments recorded in Table 3, CTAP- 
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Figure 1. Stimulation of PGE synthesis by CTAP-I (15.6 pg/ml) and 
-111 (35 pg/ml) as a function of time. 
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Figure 2. CTAP-I11 stimulation of PGE synthesis, a dose-response 
study. Values plotted are mean f SD. Incubation time was 24 hours. 
stimulate hyaluronate formation, and on a “specific ac- 
tivity’’ basis (Table 3, last column), PGE2 was the most 
potent prostaglandin tested. Several other prostaglan- 
dins also induced hyaluronate formation in the concen- 
tration tested, albeit to a lesser extent for this particular 
cell type (Table 3). 
Effect of drugs on PGE formation. The effects of 
selected drugs on CTAP-stimulated PGE2 synthesis are 
recorded in Figure 3. Both CTAP-I and CTAP-I11 stim- 
ulated PGE synthesis markedly over control levels. Cy- 
cloheximide failed to block the effect of either CTAP on 
prostaglandin synthesis and secretion (upper panel, Fig- 
ure 3). Conversely, indomethacin markedly reduced the 
stimulatory effect of both CTAP-I and CTAP-I11 on 
PGE synthesis in cultivated synovial cells. In a similar 
experiment, PGE synthesis was suppressed by acetyl- 
salicylic acid as well as by indomethacin (lower panel, 
Figure 3). It was interesting in this experiment that hy- 
drocortisone totally suppressed the stimulatory effect on 
PGE synthesis of the lymphocyte peptide, but was 
somewhat less suppressive in the case of CTAP-111. 
DISCUSSION 
Regulating synovial cell synthesis and secre- 
tion of prostaglandins may have pathophysiologic im- 
portance in view of reports documenting their tissue dis- 
tribution and studies of agents able to stimulate or 
inhibit their formation. ExDlant cultures of rheumatoid 
of these observations to serious clinical aspects of syno- 
vitis was indicated in parallel studies suggesting that 
PGE2 from rheumatoid synovium induced bone resorp- 
tion as measured by calcium release (18). Immuno- 
fluorescent studies with antisera to PGE localized pros- 
taglandin E in the synovial intimal cells of rheumatoid 
synovial tissue and showed that the intensity of PGE 
staining in synovial cells was positively correlated with 
the degree of lymphocyte infiltration (19). This latter 
finding is consistent with the possibility of a significant 
role for CTAP-I in rheumatoid synovitis, since this lym- 
phocyte-derived mediator was shown here to markedly 
stimulate PGE formation by synovial cells. 
Synthesis and secretion of PGE by human sy- 
novial and skin cells in monolayer cultures are known 
Table 3. Comparison of substances stimulating 14C-glucosamine 
incorporation by human synovial cells 
Incremental ‘‘C-hyaluro- 
nate in media* 
Concentra- CPM/2 x 
tion of lo4 cells 
additive, CPM/2 x /nmole of 





PGE 1 1 .o 
PGE2 1 .o 
PGFla 1.0 
PGF2a 1.0 
6-keto- 1 .o 
PGD2 1 .o 

































CTAP-I 50.5 7640 8321 co.01 
CTAP-I11 15.5 979 2929 10.01 
Insulin 25.0 789 947 10.01 
Serum, 714.0 1006 479 c0.01 
PGEl 1 .o 857 1221 co.01 
PGE2 1 .o 1554 2214 c0.01 
PG12 1 .o 454 647 10.01 
6-keto- 1 .0 391 557 co.10 
* Cultures consisted of 20,000 cells in 200 pl media. Incremental I4C- 
HA (over saline controls) in media was measured by scintillation 
counting after removal of free 14C-glucosamine. In both experiments, 
the mean incremental I4C-HA/20,000 cells was derived from four 
replicate well cultures for each substance. Control 14C-HA measure- 
ments (saline vehicle) were 221 f 63 CPM/20,000 cells in Experiment 
#1 and 533 f 172 CPM/20,000 cells in Experiment #2. P values for 
human$ 
PGF2a 
synovial membrane have been shown to synthesize and the significance of differences between quadruplicate test wells and 
saline control wells are shown. 
‘r Bovine insulin, + Molecular weight of albumin used for calculation in last column. 
secrete primarily PGE2 (17). Interestingly, colchicine 
stimulated PGE2 synthesis in this system. The relevance 
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Figure 3. Effect of drugs on CTAP-stimulated PGE synthesis. Drug 
concentrations were: cycloheximide, 8.7 pg/ml; indomethacin, 15.0 
pg/ml; acetylsalicylic acid, 300 pg/ml; cortisol, 1.0 pg/ml. 
to be regulatable (20). Both human interferon and the 
interferon inducer, poly(1) . poly(C), markedly stimu- 
lated PGE formation and secretion, effects totally re- 
versed by cortisol, 2.0 pg/ml. 
The present data indicate that both CTAP-I and 
CTAP-I11 stimulated synthesis of PGE in cultures of 
human connective tissue cells. It is likely that the RIA 
for PGE is actually measuring PGE2 rather than PGEl, 
in view of other data linking PGE2 to the synovium 
(17,18). Responsive cell types included both normal and 
rheumatoid synovial cells and normal dermal fibro- 
blasts. Agents known to interfere with PGE2 formation, 
including indomethacin, acetylsalicylic acid, and hydro- 
cortisone, blocked most of the CTAP-induced prosta- 
glandin synthesis, while cycloheximide was ineffective 
in this regard. The findings with acetylsalicylic acid, in- 
domethacin, and cycloheximide are consistent with the 
belief that synovial cells contain an intact, functional 
cyclooxygenase, and that the protein synthesis required 
for activation does not include this prostaglandin syn- 
thetase system. Hydrocortisone inhibition of PGE syn- 
thesis by human synovial cells probably is related to 
blockade of arachidonate release, in view of recent evi- 
dence showing that dexamethasone blocked a lipase 
specific for arachidonate in rabbit synovial cells (2 1). 
The data are consistent with our proposal that 
CTAP-induced connective tissue activation is mediated 
at least in part by endogenous prostaglandin synthesis 
(8). It is not clear whether CTAP-induced PGE syn- 
thesis influences connective tissue activation in a partic- 
ular stimulated cell by re-uptake of newly secreted 
PGE, or whether the newly formed PGE is partitioned 
in some fashion, with a portion staying within the cell of 
origin. Exogenous consequences of secreted PGE were 
suggested by the experiments showing calcium release 
in a target tissue caused by PGE2 secreted by rheuma- 
toid synovium (18). In a similar manner, our earlier 
data are compatible with an amplification mechanism 
whereby high concentrations of PGE2 secreted by one 
cell might directly stimulate GAG synthesis in a nearby 
cell; at a more distant site (at a lower concentration), it 
might serve to potentiate a threshold concentration of a 
CTAP mediator. 
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